Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay

Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
p p Read More

The company will initially develop a vaccine to tackle colorectal and pancreatic cancers

February 3, 2026 Gustave Roussy, Kahimmune Therapeutics, News, Oncology, SATT Paris-Saclay

IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease

IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
p p Read More

Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease

February 3, 2026 IBSA, News, Peyronie's disease

Cancer is a chronic disease: why don’t we treat it as one?

Cancer is a leading cause of death, and one year mortality remains high for some cancers, such as […]

February 3, 2026 Uncategorized

More adults in England are avoiding alcohol—what’s behind the trend?

Another attempt at Dry January?No, this seems to be a year round phenomenon. Latest data from the Health […]

February 3, 2026 General practice / family medicine, UK

Gaza: Israel to ban MSF after charity’s U turn on sharing Palestinian staff details

Médecins Sans Frontières is to be banned from operating in the Gaza Strip and West Bank after reversing […]

February 3, 2026 Uncategorized

Toxic metals and carcinogens found in Australian tattoo inks

An analysis of 15 commercially available tattoo inks in Australia has found levels of metals and carcinogens, including […]

February 3, 2026 Uncategorized

Trump to withhold Gavi funding until all vaccines with mercury removed

The US government will withhold funding to Gavi, the global vaccine alliance, until it stops using vaccines containing […]

February 3, 2026 Uncategorized

En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation

En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
p p Read More

The US sees around 476,000 new Lyme cases every year

February 3, 2026 En Carta Diagnostics, FDA, Lyme disease, News

ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children

ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
p p Read More

Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys

February 2, 2026 ALK, anaphylaxis, EURneffy, News

Scientists Warn: This “miracle cure” works only by damaging human cells

MMS has long been promoted as a miracle cure, but new research shows it’s essentially a toxic disinfectant. […]

February 2, 2026 Uncategorized

Posts navigation

« Previous

Posts pagination

1 2 … 1,942 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy